ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with diclofenac in 2 studies
| Studies (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Trials (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Recent Studies (post-2010) (ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination) | Studies (diclofenac) | Trials (diclofenac) | Recent Studies (post-2010) (diclofenac) |
|---|---|---|---|---|---|
| 24 | 5 | 0 | 8,874 | 1,874 | 3,616 |
| Protein | Taxonomy | ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination (IC50) | diclofenac (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 1.9 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.003 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 1.3376 | |
| Interleukin-8 | Homo sapiens (human) | 0.008 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 0.0415 | |
| Sodium- and chloride-dependent GABA transporter 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.012 | |
| Sodium- and chloride-dependent GABA transporter 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent GABA transporter 3 | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.4165 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 0.5 | |
| Sodium- and chloride-dependent betaine transporter | Rattus norvegicus (Norway rat) | 0.5 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 1.6867 | |
| Prostaglandin G/H synthase 2 | Mus musculus (house mouse) | 0.0502 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 0.5 | |
| P2Y purinoceptor 12 | Rattus norvegicus (Norway rat) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kromann-Andersen, B; Lendorf, A; Lyngdorf, P; Møller, P; Sommer, P | 1 |
| Finnerup, B; Kromann-Andersen, B; Lendorf, A; Lyngdorf, P; Mouritsen, AL; Møller, P; Rasmussen, F; Sommer, P | 1 |
2 trial(s) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and diclofenac
| Article | Year |
|---|---|
Analgesic effect and tolerance of Voltaren and Ketogan in acute renal or ureteric colic.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Allylamine; Amines; Analgesics; Clinical Trials as Topic; Colic; Diclofenac; Double-Blind Method; Drug Combinations; Female; Humans; Kidney Diseases; Male; Meperidine; Middle Aged; Prospective Studies; Random Allocation; Ureteral Diseases | 1989 |
[Acute pain due to kidney/ureter stones treated with intramuscular Voltaren or Ketogan].
Topics: Adult; Aged; Allylamine; Amines; Analgesics, Opioid; Diclofenac; Drug Combinations; Female; Humans; Injections, Intramuscular; Kidney Calculi; Male; Meperidine; Middle Aged; Pain; Ureteral Calculi | 1987 |